|
BIOSCIENCE PORTFOLIO
| |
|
Agile Planet solves complex safety and controls problems for the medical, industrial and defense industries with its state-of-the-art robotics and simulation software. RobotLogix, Kinematix, AgileMedix and other Agile Planet software give OEMs and institutions the tools they need to rapidly develop controllers, design packages, and off-line planning and task optimization software. Agile Planet holds exclusive rights to its core technology, which is based on over 15 years of research and development at The University of Texas at Austin. Developed with funding from the U.S. Department of Energy (DOE), NASA, DARPA and other agencies, this software has over 1000 users worldwide including the German Aerospace Center (DLR), MIT, and the Indian Institute of Technology, Larsen and Toubro, Toshiba, Samsung, Kuka and ABB. |
| |
|
Digital Pathology NewCo is a new company devoted to enhancing the field of digital pathology. It is currently developing a multispectral imaging solution that will enable pathology to evolve from a qualitative practice to a quantitative science. The product will exploit new technology advances, and the company has also found novel uses for existing technologies. As a result, the company is positioned to pioneer the next generation of digital pathology technology and actively seeks technical collaborations. Please contact NewCo through jhanover@ati.utexas.edu for additional information. |
| |
|
Infinagen is a startup company founded to develop, manufacture, market and sell the unique encoded hydrogel Microdysc technology. The basic technology was developed at The University of Texas at Austin, and the company has shown the ability to analyze DNA, proteins, enzymes and pH with the Microdyscs. These Microdyscs, used within the Infinagen system, are developed by the company as an inexpensive diagnostic testing platform across many applications. |
| |
|
Minimus Spine develops ozone technology to treat disc herniations. The company is founded on an existing body of literature which demonstrates that ozone can reduce the size of the herniation and give patients lasting relief without multiple spinal injections or surgery.
|
| |
|
Savara is a pharmaceutical company developing novel respiratory therapeutics by utilizing their proprietary NanoCluster dry powder aerosol drug delivery platform. The breakthrough process utilizes nanotechnology to create high performance dry powder aerosols that are assembled directly from the nanoparticles and can blend multiple APIs while maintaining proper therapeutic ratios. The therapeutics can then be delivered via oral pulmonary or nasal routes using off-the-shelf dry powder inhalers. In addition to developing their own therapeutics, Savara is working with partner companies to enable pulmonary delivery of their proprietary compounds.
|
| |
|
Terapio /T?•rah•p?•?/ is a biopharmaceutical company developing a pipeline of therapeautics based on the normally-occurring transport protein RLIP76 that moves free-radical toxins out of cells before significant damage can occur. Although naturally present in cells, increasing the amount of RLIP76 protein available to normal cells affords them an even greater ability to deal with toxins from a variety of insults, including chemicals, burns and radiation.
|
| |
|
|
|
